Cigna Insurance Company has updated its medical coverage policy to include Kerecis products for the treatment of diabetic foot ulcers. This decision expands the range of advanced wound care options available to Cigna members.
Kerecis products, which are intact fish-skin grafts, offer a biological solution for complex wound healing. Their inclusion in Cigna's coverage policy signifies recognition of their clinical value in managing challenging conditions like diabetic foot ulcers.
This operational milestone enhances Cigna's commitment to providing comprehensive and effective treatments for its members. It ensures that patients with diabetic foot ulcers have access to innovative therapies that can improve health outcomes.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.